deltatrials
Completed PHASE1 NCT01116804

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

Sponsor: University Ghent

Conditions Primary Liver Cancer
Interventions MRI after treatment MRI of the liver before start of treatment PET scan after treatment PET-scan before treatment start
Updated 6 times since 2017 Last updated: Dec 13, 2022 Started: Jun 16, 2010 Primary completion: Jan 20, 2020 Completion: Jan 20, 2020

This PHASE1 trial investigates Primary Liver Cancer and is currently completed. University Ghent leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Unknown Status → Completed

  4. Jan 2021 — Jan 2023 [monthly]

    Unknown Status PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1

    First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Ghent
  • University Hospital, Ghent
Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ghent, Belgium